Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells. 1980

D H Ho, and C J Carter, and N S Brown, and J Hester, and K McCredie, and R S Benjamin, and E J Freireich, and G P Bodey

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D010770 Phosphotransferases A rather large group of enzymes comprising not only those transferring phosphate but also diphosphate, nucleotidyl residues, and others. These have also been subdivided according to the acceptor group. (From Enzyme Nomenclature, 1992) EC 2.7. Kinases,Phosphotransferase,Phosphotransferases, ATP,Transphosphorylase,Transphosphorylases,Kinase,ATP Phosphotransferases
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013767 Tetrahydrouridine An inhibitor of nucleotide metabolism. NSC-112907,NSC 112907,NSC112907

Related Publications

D H Ho, and C J Carter, and N S Brown, and J Hester, and K McCredie, and R S Benjamin, and E J Freireich, and G P Bodey
January 1992, Chemotherapy,
D H Ho, and C J Carter, and N S Brown, and J Hester, and K McCredie, and R S Benjamin, and E J Freireich, and G P Bodey
October 1977, Cancer research,
D H Ho, and C J Carter, and N S Brown, and J Hester, and K McCredie, and R S Benjamin, and E J Freireich, and G P Bodey
February 1991, Danish medical bulletin,
D H Ho, and C J Carter, and N S Brown, and J Hester, and K McCredie, and R S Benjamin, and E J Freireich, and G P Bodey
August 1970, Cancer research,
D H Ho, and C J Carter, and N S Brown, and J Hester, and K McCredie, and R S Benjamin, and E J Freireich, and G P Bodey
October 1979, Cancer research,
D H Ho, and C J Carter, and N S Brown, and J Hester, and K McCredie, and R S Benjamin, and E J Freireich, and G P Bodey
June 1968, Cancer research,
D H Ho, and C J Carter, and N S Brown, and J Hester, and K McCredie, and R S Benjamin, and E J Freireich, and G P Bodey
May 1982, Cancer research,
D H Ho, and C J Carter, and N S Brown, and J Hester, and K McCredie, and R S Benjamin, and E J Freireich, and G P Bodey
December 1997, Leukemia,
D H Ho, and C J Carter, and N S Brown, and J Hester, and K McCredie, and R S Benjamin, and E J Freireich, and G P Bodey
January 1991, Leukemia research,
D H Ho, and C J Carter, and N S Brown, and J Hester, and K McCredie, and R S Benjamin, and E J Freireich, and G P Bodey
January 1985, Hematological oncology,
Copied contents to your clipboard!